|
[1] LORINCZ MT. Wilson disease and related copper disorders[J]. Handb Clin Neurol, 2018, 147:279-292.
|
|
[2] CZONKOWSKA A, LITWIN T, DUSEK P, et al. Wilson disease[J]. Nat Rev Dis Primers, 2018, 4 (1) :21.
|
|
[3] VAIRO FPE, CHWAL BC, PERINI S, et al. A systematic review and evidence-based guideline for diagnosis and treatment of Menkes disease[J]. Mol Genet Metab, 2019, 126 (1) :6-13.
|
|
[4] BANDMANN O, WEISS KH, KALER SG. Wilson's disease and other neurological copper disorders[J]. Lancet Neurol, 2015, 14 (1) :103-113.
|
|
[5] HERMANN W. Classification and differential diagnosis of Wilson's disease[J]. Ann Transl Med, 2019, 7 (Suppl 2) :s63.
|
|
[6] KALER SG. Inborn errors of copper metabolism[J]. Handb Clin Neurol, 2013, 113:1745-1754.
|
|
[7] MADSEN E, GITLIN JD. Copper and iron disorders of the brain[J]. Annu Rev Neurosci, 2007, 30:317-337.
|
|
[8] ROBERTS EA, SCHILSKY ML, American Association for Study of Liver Diseases (AASLD) . Diagnosis and treatment of Wilson disease:An update[J]. Hepatology, 2008, 47 (6) :2089-2111.
|
|
[9] LI XH, ZHANG XX. Progress in diagnosis and management of Wilson's disease[J]. J Diagn Concepts Pract, 2009, 8 (2) :222-229. (in Chinese) 李新华, 张欣欣.肝豆状核变性诊疗进展———美国肝病学会诊疗指南专题报道[J].诊断学理论与实践, 2009, 8 (2) :222-229.
|
|
[10] European Association for Study of Liver. EASL clinical practice guidelines:Wilson's disease[J]. J Hepatol, 2012, 56 (3) :671-685.
|
|
[11] SCHEIBER IF, BRHA R, DUEK P. Pathogenesis of Wilson disease[J]. Handb Clin Neurol, 2017, 142:43-55.
|
|
[12] LO C, BANDMANN O. Epidemiology and introduction to the clinical presentation of Wilson disease[J]. Handb Clin Neurol, 2017, 142:7-17.
|
|
[13] CHEN SR, CHONG YT, LI XH. Clinical diagnosis of genetic liver disease[J]. Chin J Hepatol, 2018, 26 (12) :894-897. (in Chinese) 陈淑如, 崇雨田, 李新华.遗传代谢性肝病的临床基因诊断[J].中华肝脏病杂志, 2018, 26 (12) :894-897.
|
|
[14] SCHILSKY ML. Wilson disease:Diagnosis, treatment, and follow-up[J]. Clin Liver Dis, 2017, 21 (4) :755-767.
|
|
[15] LUTSENKO S, LESHANE ES, SHINDE U. Biochemical basis of regulation of human copper-transporting ATPases[J].Arch Biochem Biophys, 2007, 463 (2) :134-148.
|
|
[16] Parkinson's Disease and Movement Disorders Study Group, Neurology Branch of Chinese Medical Association; Inherited Disease Study Group, Neurology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of hepatolenticular degeneration[J]. Chin J Neurol, 2008, 41 (8) :566-569. (in Chinese) 中华医学会神经病学分会帕金森病及运动障碍学组, 中华医学会神经病学分会遗传病学组.肝豆状核变性的诊断与治疗指南[J].中华神经科杂志, 2008, 41 (8) :566-569.
|
|
[17] YANG X, TONG DJ, LIANG J, et al. Ceruloplasmin level of patients with liver disease in China[J]. Chin J Intern Med, 2005, 44 (1) :13-15. (in Chinese) 杨旭, 童德军, 梁骏, 等.中国肝病患者血清铜蓝蛋白水平的研究[J].中华内科杂志, 2005, 44 (1) :13-15.
|
|
[18] YANG X, TANG XP, ZHANG YH, et al. Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample[J].Hepatology, 2015, 62 (6) :1731-1741.
|
|
[19] MIYAJIMA H. Aceruloplasminemia[J]. Neuropathology, 2015, 35 (1) :83-90.
|
|
[20] MARCHI G, BUSTI F, LIRA ZIDANES A, et al. Aceruloplasminemia:A severe neurodegenerative disorder deserving an early diagnosis[J]. Front Neurosci, 2019, 13:325.
|
|
[21] KONO S. Aceruloplasminemia:An update[J]. Int Rev Neurobiol, 2013, 110:125-151.
|
|
[22] NG BG, FREEZE HH. Perspectives on glycosylation and its congenital disorders[J]. Trends Genet, 2018, 34 (6) :466-476.
|
|
[23] MARQUES-DA-SILVA D, DOS REIS FERREIRA V, MONTICELLI M, et al. Liver involvement in congenital disorders of glycosylation (CDG) . A systematic review of the literature[J]. J Inherit Metab Dis, 2017, 40 (2) :195-207.
|
|
[24] JANSEN JC, CIRAK S, van SCHERPENZEEL M, et al. CCDC115deficiency causes a disorder of Golgi homeostasis with abnormal protein glycosylation[J]. Am J Hum Genet, 2016, 98 (2) :310-321.
|
|
[25] JANSEN JC, TIMAL S, van SCHERPENZEEL M, et al. TMEM199deficiency is a disorder of Golgi homeostasis characterized by elevated aminotransferases, alkaline phosphatase, and cholesterol and abnormal glycosylation[J]. Am J Hum Genet, 2016, 98 (2) :322-330.
|
|
[26] JANSEN EJ, TIMAL S, RYAN M, et al. ATP6AP1 deficiency causes an immunodeficiency with hepatopathy, cognitive impairment and abnormal protein glycosylation[J]. Nat Commun, 2016, 7:11600.
|
|
[27] GIRARD M, POUJOIS A, FABRE M, et al. CCDC115-CDG:A new rare and misleading inherited cause of liver disease[J]. Mol Genet Metab, 2018, 124 (3) :228-235.
|
|
[28] European Association for the Study of the Liver. EASL clinical practice guidelines:Management of cholestatic liver diseases[J]. J Hepatol, 2009, 51 (2) :237-267.
|
DownLoad: